IBEX Stock Analysis: IBEX | NASDAQ
Information Technology Services | NASDAQ, USA | Market Cap: 606m USD | 12M Return: 26.3% | BMG4690M1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.73M
EPS Trend: 97.0%
Qual. Beats: -1
Rev. Trend: 91.8%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
Seasonality 6.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
IBEX Limited (NASDAQ: IBEX) is a technology-enabled provider of end-to-end customer lifecycle experience (CX) solutions, operating customer engagement and customer acquisition delivery centers in the United States and internationally. The company is headquartered in Washington, D.C., was incorporated in 2017, and went public on the NASDAQ in August 2020. It was formerly known as IBEX Holdings Limited, adopting its current name in September 2019.
The companys offerings are organized around three core products: ibex Connect, which delivers outsourced customer service, technical support, revenue generation, and back-office services through an omnichannel CX model integrating voice, email, chat, SMS, and social media; ibex Digital, a customer acquisition solution combining digital marketing, e-commerce technology, and platform solutions; and Wave iX, an AI-powered customer experience platform.
IBEX serves a diverse set of end markets, including government, banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utilities. As a business process outsourcing (BPO) provider classified within the Information Technology / Application Software segment, IBEX operates in the broader customer experience management industry, where AI-driven platforms and omnichannel engagement tools have become standard components of outsourced service delivery.
- Wave iX AI platform adoption expands enterprise client pipeline
- Philippines wage inflation pressures offshore delivery margins
- Healthcare and fintech verticals drive new contract wins
| Net Income: 46.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.10 > 1.0 |
| NWC/Revenue: 14.61% < 20% (prev 11.76%; Δ 2.85% < -1%) |
| CFO/TA 0.19 > 3% & CFO 59.0m > Net Income 46.3m |
| Net Debt (29.9m) to EBITDA (77.2m): 0.39 < 3 |
| Current Ratio: 2.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.9m) vs 12m ago 2.77% < -2% |
| Gross Margin: 29.17% > 18% (prev 30.91%; Δ -1.74% > 0.5%) |
| Asset Turnover: 221.2% > 50% (prev 204.3%; Δ 16.86% > 0%) |
| Interest Coverage Ratio: 61.18 > 6 (EBIT TTM 57.3m / Interest Expense TTM 936k) |
| A: 0.30 (Total Current Assets 179.6m - Total Current Liabilities 85.5m) / Total Assets 309.1m |
| B: 0.23 (Retained Earnings 72.1m / Total Assets 309.1m) |
| C: 0.20 (EBIT TTM 57.3m / Avg Total Assets 291.2m) |
| D: 1.23 (Book Value of Equity 170.2m / Total Liabilities 138.9m) |
| Altman-Z'' = 5.37 = AAA |
| DSRI: 0.95 (Receivables 129.5m/118.7m, Revenue 644.1m/558.3m) |
| GMI: 1.06 (GM 30.91% / 29.17%) |
| AQI: 0.90 (AQ_t 0.11 / AQ_t-1 0.12) |
| SGI: 1.15 (Revenue 644.1m / 558.3m) |
| TATA: -0.04 (NI 46.3m - CFO 59.0m) / TA 309.1m) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 24, 2026, the stock is trading at USD 47.23 with a total of 93,357 shares traded. Over the past week, the price has changed by +3.47%, over one month by +10.71%, over three months by +46.63% and over the past year by +26.32%.
Current recommended Stop Loss: 43.50 (which is 7.9% or 2.8 ATR below the current price).
IBEX has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold IBEX.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42 | -11.1% |
P/E Trailing = 14.5831
P/E Forward = 11.5875
P/S = 0.941
P/B = 3.3253
Revenue TTM = 644.1m USD
EBIT TTM = 57.3m USD
EBITDA TTM = 77.2m USD
Long Term Debt = 47.6m USD (estimated: total debt 62.4m - short term 14.8m)
Short Term Debt = 14.8m USD (from shortTermDebt, last quarter)
Debt = 62.4m USD (from shortLongTermDebtTotal, last quarter) (leases 62.4m already included)
Net Debt = 29.9m USD (calculated: Debt 62.4m - CCE 32.6m)
Enterprise Value = 636.0m USD (606.1m + Debt 62.4m - CCE 32.6m)
Interest Coverage Ratio = 61.18 (Ebit TTM 57.3m / Interest Expense TTM 936k)
EV/FCF = 20.39x (Enterprise Value 636.0m / FCF TTM 31.2m)
FCF Yield = 4.90% (FCF TTM 31.2m / Enterprise Value 636.0m)
FCF Margin = 4.84% (FCF TTM 31.2m / Revenue TTM 644.1m)
Net Margin = 7.19% (Net Income TTM 46.3m / Revenue TTM 644.1m)
Gross Margin = 29.17% ((Revenue TTM 644.1m - Cost of Revenue TTM 456.2m) / Revenue TTM)
Gross Margin QoQ = 34.60% (prev 26.53%)
Tobins Q-Ratio = 2.06 (Enterprise Value 636.0m / Total Assets 309.1m)
Interest Expense / Debt = 1.50% (Interest Expense 936k / Debt 62.4m)
Taxrate = 11.10% (6.03m / 54.3m)
NOPAT = 50.9m (EBIT 57.3m * (1 - 11.10%))
Current Ratio = 2.10 (Total Current Assets 179.6m / Total Current Liabilities 85.5m)
Debt / Equity = 0.37 (Debt 62.4m / totalStockholderEquity, last quarter 170.2m)
Debt / EBITDA = 0.39 (Net Debt 29.9m / EBITDA 77.2m)
Debt / FCF = 0.96 (Net Debt 29.9m / FCF TTM 31.2m)
Total Stockholder Equity = 157.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.91% (Net Income 46.3m / Total Assets 309.1m)
RoE = 29.46% (Net Income TTM 46.3m / Total Stockholder Equity 157.3m)
RoCE = 27.95% (EBIT 57.3m / Capital Employed (Equity 157.3m + L.T.Debt 47.6m))
RoIC = 24.69% (NOPAT 50.9m / Invested Capital 206.2m)
WACC = 7.20% (E(606.1m)/V(668.5m) * Re(7.80%) + D(62.4m)/V(668.5m) * Rd(1.50%) * (1-Tc(0.11)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.64 | Cagr: -8.16%
[DCF] Terminal Value 77.86% ; FCFF base≈29.6m ; Y1≈33.8m ; Y5≈48.9m
[DCF] Fair Price = 53.29 (EV 737.4m - Net Debt 29.9m = Equity 707.6m / Shares 13.3m; r=8.35% [WACC [floored]]; 5y FCF grow 14.29% → 2.50% )
EPS Correlation: 97.04 | EPS CAGR: 31.13% | SUE: -3.71 | # QB: -1
Revenue Correlation: 91.77 | Revenue CAGR: 9.19% | SUE: 0.94 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.90 | Chg30d=+4.05% | Revisions=+40% | Analysts=2
EPS next Quarter (2026-12-31): EPS=0.91 | Chg30d=+2.82% | Revisions=+0% | Analysts=2
EPS current Year (2027-06-30): EPS=3.70 | Chg30d=+2.07% | Revisions=+0% | GrowthEPS=+5.1% | GrowthRev=+10.6%
EPS next Year (2028-06-30): EPS=4.08 | Chg30d=-0.37% | Revisions=+25% | GrowthEPS=+10.4% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: +38% (up=4, down=1)